Jaguar Health (NASDAQ: JAGX)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-12 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.170 | -0.400 | -0.2300 | ||||
REV | 1.620M | 2.625M | 1.005M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Jaguar Health (NASDAQ: JAGX) through any online brokerage.
Other companies in Jaguar Health’s space includes: Cingulate (NASDAQ:CING), Graybug Vision (NASDAQ:GRAY), Cumberland (NASDAQ:CPIX), Onconova Therapeutics (NASDAQ:ONTX) and Akanda (NASDAQ:AKAN).
The latest price target for Jaguar Health (NASDAQ: JAGX) was reported by Cantor Fitzgerald on Wednesday, July 7, 2021. The analyst firm set a price target for 5.00 expecting JAGX to rise to within 12 months (a possible 1522.32% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Jaguar Health (NASDAQ: JAGX) is $0.3082 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Jaguar Health.
Jaguar Health’s Q2 earnings are confirmed for Friday, August 12, 2022.
There is no upcoming split for Jaguar Health.
Jaguar Health is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.